Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Shares Outstanding: 2020-2021

Historic Shares Outstanding for Design Therapeutics (DSGN) over the last 2 years, with Sep 2021 value amounting to $55.2 million.

  • Design Therapeutics' Shares Outstanding rose 247.60% to $55.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $55.2 million, marking a year-over-year increase of 247.60%. This contributed to the annual value of $16.0 million for FY2020, which is N/A change from last year.
  • Per Design Therapeutics' latest filing, its Shares Outstanding stood at $55.2 million for Q3 2021, which was up 0.20% from $55.1 million recorded in Q2 2021.
  • In the past 5 years, Design Therapeutics' Shares Outstanding ranged from a high of $55.2 million in Q3 2021 and a low of $15.7 million during Q1 2020.
  • In the last 2 years, Design Therapeutics' Shares Outstanding had a median value of $16.0 million in 2020 and averaged $32.7 million.
  • Data for Design Therapeutics' Shares Outstanding shows a peak YoY skyrocketed of 250.80% (in 2021) over the last 5 years.
  • Design Therapeutics' Shares Outstanding (Quarterly) stood at $16.0 million in 2020, then soared by 247.60% to $55.2 million in 2021.
  • Its last three reported values are $55.2 million in Q3 2021, $55.1 million for Q2 2021, and $55.0 million during Q1 2021.